Attached files
file | filename |
---|---|
EX-31 - EXHIBIT 31 - Phoenix Life Sciences International Limited. | medijane10k15ex31.htm |
10-K - FORM 10-K - Phoenix Life Sciences International Limited. | mjmd10k15v10.htm |
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of MediJane Holdings Inc. (the "Company") on Form 10-K for the year ended February 28, 2015 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Lewis Spike Humer, Interim Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
/s/Lewis Spike Humer
Lewis Spike Humer
Interim Chief Executive Officer
July 28, 2015
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of MediJane Holdings Inc. (the "Company") on Form 10-K for the year ended February 28, 2015 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Russel Stone, Interim Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
/s/Russell Stone
Russell Stone
Interim Chief Financial Officer
July 28, 2015